Correlation Between Walt Disney and Pfizer
Can any of the company-specific risk be diversified away by investing in both Walt Disney and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walt Disney and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walt Disney and Pfizer Inc, you can compare the effects of market volatilities on Walt Disney and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walt Disney with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walt Disney and Pfizer.
Diversification Opportunities for Walt Disney and Pfizer
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Walt and Pfizer is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Walt Disney and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and Walt Disney is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walt Disney are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of Walt Disney i.e., Walt Disney and Pfizer go up and down completely randomly.
Pair Corralation between Walt Disney and Pfizer
If you would invest 0.00 in Walt Disney on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Walt Disney or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 1.61% |
| Values | Daily Returns |
Walt Disney vs. Pfizer Inc
Performance |
| Timeline |
| Walt Disney |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
OK
| Pfizer Inc |
Walt Disney and Pfizer Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Walt Disney and Pfizer
The main advantage of trading using opposite Walt Disney and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walt Disney position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.| Walt Disney vs. Agrometal SAI | Walt Disney vs. Transportadora de Gas | Walt Disney vs. Harmony Gold Mining | Walt Disney vs. Telecom Argentina |
| Pfizer vs. Harmony Gold Mining | Pfizer vs. Agrometal SAI | Pfizer vs. United States Steel | Pfizer vs. Telecom Argentina |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |